Pregled bibliografske jedinice broj: 82755
Successful treatment of risperidone-induced sexual dysfunction with bromocriptine
Successful treatment of risperidone-induced sexual dysfunction with bromocriptine // Abstracts of the XXIIIrd Collegium Internationale Neuro-psychophyrmacologicum (CINP) Congress ; u: The International Journal of Neuropsychopharmacology 5 (2002) (S1) / Lerer, Bernard (ur.).
Port Chester (NY): Cambridge University Press, 2002. str. S171-S171 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 82755 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Successful treatment of risperidone-induced sexual dysfunction with bromocriptine
Autori
Šagud, Marina ; Jakovljević, Miro ; Mihaljević-Peleš, Alma ; Hotujac, Ljubomir ; Pivac, Nela ; Muck-Šeler, Dorotea
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Abstracts of the XXIIIrd Collegium Internationale Neuro-psychophyrmacologicum (CINP) Congress ; u: The International Journal of Neuropsychopharmacology 5 (2002) (S1)
/ Lerer, Bernard - Port Chester (NY) : Cambridge University Press, 2002, S171-S171
Skup
Collegium Internationale Neuro-psychophyrmacologicum Congress (23 ; 2002)
Mjesto i datum
Montréal, Kanada, 23.06.2002. - 27.06.2002
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
schizophrenia; risperidone; bromocriptine; sexual dysfunction
Sažetak
Risperidone is an atypical antipsychotic, proved to be safe and effective in the treatment of schizophrenia. However, it has been reported to cause sexual dysfunction in males. This adverse event is beleived to be induced by increased prolactin levels and consequently decreased testosterone levels. The aim of the report is to present three case reports of risperidone-induced sexual dysfunction that was successfully reversed with addition of bromocriptine. Three males with the diagnoses of schizophrenia, aged 21, 24 and 49 years, were treated with risperidone 4 mg/daily. After two months of risperidone treatment, they complained on erectile dysfunctions and decreased libido. Bromocriptine 2, 5 mg in the morning was added to the current risperidone regimen. The aforementioned adverse events dissapeared in the next two to four weeks in all three patients. No worsening of psychosis was observed. In male schizophrenic patients with risperidone-induced sexual dysfunctions, who are otherwise in a stable remission, bromocriptine addition to risperidone dosage regimen should be considered as an useful alternative to the cessation of risperidone.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Alma Mihaljević-Peleš
(autor)
Marina Šagud
(autor)
Dorotea Muck-Šeler
(autor)
Miro Jakovljević
(autor)
Ljubomir Hotujac
(autor)
Nela Pivac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE